AVN...PRIORITY REVIEW- GRANTED BY THE FDA!
Breaking news just out & over the wire...
AVN's potential multi-billion dollar blockuster drug,
Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA...
"The FDA has granted AVANIR's NDA a Priority Review, which is an
accelerated six-month review timeline."
Business Wire
http://biz.yahoo.com/bw/050418/186078.html?.v=1
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Insider Buying / * AVN CEO Aquires 2M Shares*~
This is extremely BULLISH and the short bashers are in a nervous
frenzy!
~~~STRONG BUY~~~
YAKATAN, GERALD J.: Declared Holdings
Company/Relationship Reported Shares Ownership
AVANIR PHARMACEUTICL
Chief Executive Officer
AMEX:AVN
8-Mar-05 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
share.
(Value of $5,300,000)
Also, biotech guru, Jonathan Silverman recently did a private purchase
of 900,000 shares bring him in control of 8,775,000 shares.
Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
blockbuster drug in Phase 3 with remarkable results up for FDA
Priority Approval, fantastic Anthrax Antibody, unique Cancer
Compound unlike anything ever seen before, IgE for allergies and
asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-
cholestoral drug, Xenerex subsidiary for the production of the only
completely human mABs.
http://www.avanir.com http://www.xenerex.com